作者
John J Atherton, Andrew Sindone, Carmine G De Pasquale, Andrea Driscoll, Peter S MacDonald, Ingrid Hopper, Peter Kistler, Tom G Briffa, James Wong, Walter P Abhayaratna, Liza Thomas, Ralph Audehm, Phillip J Newton, Joan OˈLoughlin, Cia Connell, Maree Branagan
发表日期
2018/10
期刊
Medical Journal of Australia
卷号
209
期号
8
页码范围
363-369
简介
Introduction: Heart failure (HF) is a clinical syndrome that is secondary to an abnormality of cardiac structure or function. These clinical practice guidelines focus on the diagnosis and management of HF with recommendations that have been graded on the strength of evidence and the likely absolute benefit versus harm. Additional considerations are presented as practice points.
Main recommendations:
- Blood pressure and lipid lowering decrease the risk of developing HF. Sodium–glucose cotransporter 2 inhibitors decrease the risk of HF hospitalisation in patients with type 2 diabetes and cardiovascular disease.
- An echocardiogram is recommended if HF is suspected or newly diagnosed.
- If an echocardiogram cannot be arranged in a timely fashion, measurement of plasma B‐type natriuretic peptides improves diagnostic accuracy.
- Angiotensin‐converting enzyme inhibitors, β‐blockers and mineralocorticoid …
学术搜索中的文章
JJ Atherton, A Sindone, CG De Pasquale, A Driscoll… - Medical Journal of Australia, 2018